肺炎:一个病例报告
1Internal Medicine Program, University of Connecticut, Farmington, CT, USA. gri@uchc.edu.
Journal of medical case reports
|February 11, 2024
概括
如果不及早诊断,肺囊炎 (PJP) 的肺炎可能是致命的,特别是在没有明显的风险因素的患者中. 这一案例凸显了诊断方面的挑战,以及在重症肺炎中及时进行PJP向治疗的必要性.
科学领域:
- 医学案例研究 医学案例研究
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 肺炎 (PJP) 是一种严重的,危及生命的感染,主要影响免疫力低下的个体,通常与人体免疫缺陷病毒 (HIV) 相关.
- 早期识别和治疗PJP对于患者的生存至关重要,但诊断可能具有挑战性,特别是在缺乏明显免疫抑制风险因素的患者中.
研究的目的:
- 在没有已知的危险因素的患者中描述一个具有挑战性的PJP肺炎病例.
- 突出诊断困难和认知偏差在延迟PJP诊断和治疗中的潜在影响.
- 强调早期经验性PJP治疗在严重的肺炎和无法解释的恶化病例中的重要性.
主要方法:
- 一个71岁的男性出现亚急性缺氧呼吸衰竭的病例报告.
- 初始治疗是使用广谱抗生素和类固醇,随后的病情恶化需要输管治疗和ICU转移.
- 支气管镜检查显示PJP,随后开始向治疗.
主要成果:
- 患者出现多焦点肺炎和磨砂玻璃不透明性,最初为常规肺炎进行治疗,但没有改善.
- 支气管镜检查证实了PJP,但患者患上了耐火性休克和多器官衰竭,最终因感染而死亡.
- 尸检检测显示该患者是HIV-1阳性,这表明诊断和治疗的显著延迟.
结论:
- 在没有明显的风险因素的情况下,PJP肺炎可能会出现,这会给诊断带来挑战,如果不及早发现,可能会导致致命的结果.
- 医疗保健提供者之间的认知偏见可能导致诊断延迟和治疗启动.
- 及时诊断,可能通过在高风险肺炎呈现的早期经验性PJP向治疗,对于减轻发病率和死亡率至关重要.
相关概念视频
01:30Pneumonia I: Introduction
238
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
238
01:29Pneumonia II: Pathophysiology
272
The pathophysiology of pneumonia involves the following steps:
272
01:30Pneumonia III: Complications and Assessment
219
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
219
01:28Pneumonia IV: Management
327
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
327
01:30Pneumonia V: Nursing management and Prevention
2.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
01:21Acute Respiratory Failure-II
234
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
234